logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table PDU-6. Estimated trends in the prevalence of problem and injecting drug use — 2004 to 2009 (rate per 1000 population aged 15 to 64): Combined estimates per country [see all tables in this series...]

Part (iv) Estimated trends of problem stimulant use

Country200420052006200720082009Drug use [1]Method [1]
Czech Republic:2.822.692.842.873.41PSUTM


 Data represents a selection based on the availablity of the same calculation method over the time. In some countries more estimates might be available. The selection was made in order for the trend to be unbiased. In some countries data are insufficient to report.  

 Target groups may vary between countries owing to different methods and data sources; therefore comparisons should be made with caution. 

 For more details see Tables PDU-1, PDU-102 and PDU-103 in the Statistical bulletin 2011. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page 

 See also EMCDDA project (2003): National prevalence estimates of problem drug use in the European Union, 1995–2000, CT.00.RTX.23, EMCDDA, Lisbon, coordinated by the Institut für Therapieforschung, Munich. 

 [1] - POU = Problem opioid use; PDU = Problem drug use. TM = Treatment Multiplier ; HM = HIV Multiplier ; MM = Mortality Multiplier ; MI = Multivariate Indicator Method ; PM = Police Multiplier ; TP = Truncated Poisson ; CM = Combined Methods. CR = Capture Recapture, OT = Other Methods. 


 Reitox national focal points 

 2010 REITOX National Reports - Fonte PDU template 

(see the help page for information about formats etc.)

Page last updated: Monday, 04 July 2011